Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial (Q41082307)
Jump to navigation
Jump to search
scientific article published on 8 November 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial |
scientific article published on 8 November 2013 |
Statements
1 reference
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial (English)
1 reference
1 reference
George Wilding
1 reference
Fred Saad
1 reference
Peter J Goebell
1 reference
Christopher J Logothetis
1 reference
John C Araujo
1 reference
Géralyn C Trudel
1 reference
Andrew J Armstrong
1 reference
Evan Y Yu
1 reference
Joaquim Bellmunt
1 reference
John McCaffrey
1 reference
Sergio V Serrano
1 reference
Vsevolod B Matveev
1 reference
Eleni Efstathiou
1 reference
Stephane Oudard
1 reference
Bruce Sizer
1 reference
Axel Heidenreich
1 reference
Johann S de Bono
1 reference
Stephen Begbie
1 reference
Jun H Hong
1 reference
Eduardo Richardet
1 reference
Enrique Gallardo
1 reference
Prashni Paliwal
1 reference
Susan Durham
1 reference
Shinta Cheng
1 reference
8 November 2013
1 reference
1 reference
14
1 reference
13
1 reference
1307-1316
1 reference
Identifiers
1 reference
1 reference
1 reference